What is the appropriate workup and management for a 66-year-old woman with two months of incomplete bladder emptying, urinary incontinence, foul‑smelling urine, abdominal distention, nausea, who recently stopped liraglutide (Victoza) and is taking glimepiride and metformin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Immediate Workup and Management

This patient requires urgent evaluation for urinary retention with likely complicated urinary tract infection, and the priority is to assess post-void residual volume, obtain urine culture, and rule out acute urinary retention or overflow incontinence.

Initial Diagnostic Workup

Immediate Assessments Required

Bladder ultrasound or bladder scan to measure post-void residual (PVR) volume is the single most critical first step. The combination of incomplete emptying, foul-smelling urine, and abdominal distention strongly suggests urinary retention with possible overflow incontinence 1.

Urinalysis and urine culture before any antibiotic treatment. In older women, atypical UTI presentations are common, including nausea, functional decline, and altered symptoms 2. However, foul-smelling urine alone does not confirm UTI—bacteriuria is common in older adults without infection 2.

Key Clinical Considerations

The temporal relationship is critical here: symptoms began 2 months ago, and she discontinued Victoza 1 month ago after 3 months of use. Gastrointestinal adverse reactions from liraglutide (Victoza) occur in 18-20% of patients (nausea) and 10-12% (diarrhea), typically during the first 2-3 months 3. However, urinary retention is not a recognized adverse effect of liraglutide.

The combination of glimepiride and metformin does not cause urinary retention 4. Look instead for:

  • Neurologic causes (diabetes-related autonomic neuropathy)
  • Anatomic obstruction (pelvic organ prolapse, masses)
  • Medication effects from other drugs (anticholinergics, antihistamines, decongestants)

Diagnostic Algorithm

If PVR >150-200 mL:

  • Neurologic examination focusing on sacral nerve function, perineal sensation, anal sphincter tone
  • Pelvic examination to assess for prolapse, masses, or anatomic obstruction 5
  • Abdominal examination to palpate for distended bladder (the "abdominal distention" may actually be bladder distention) 6
  • Consider urodynamic studies if initial workup is unrevealing, as underactive detrusor can present with these exact symptoms 7, 6

If PVR <150 mL but symptoms persist:

  • This represents the "feeling of incomplete emptying" without significant retention 8
  • Evaluate for overactive bladder symptoms
  • Consider uroflowmetry to assess time to maximum flow rate 8

Management Strategy

For Confirmed UTI (positive culture with symptoms):

Prescribe antibiotics only if there is dysuria PLUS systemic signs (fever >37.8°C, rigors, delirium) OR frequency/urgency/incontinence of recent onset 2. Do not treat based solely on foul-smelling urine or cloudy urine—these are insufficient criteria in older adults 2.

First-line options when treating:

  • Nitrofurantoin (preferred due to low resistance)
  • Fosfomycin
  • Avoid broad-spectrum agents unless culture dictates otherwise 9

For Urinary Retention (PVR >150-200 mL):

Initiate clean intermittent catheterization (CIC) as the primary management 7. This is superior to indwelling catheterization for preventing complications.

Do NOT treat asymptomatic bacteriuria—this increases antimicrobial resistance and recurrent UTI episodes 9.

Critical Pitfall to Avoid

Do not classify this as a "complicated UTI" simply because she is older or has diabetes. Reserve "complicated" designation for structural/functional urinary tract abnormalities, immunosuppression, or pregnancy 9. Overclassification leads to unnecessary broad-spectrum antibiotic use.

Diabetes Management Adjustments

Implement continuous glucose monitoring as she has agreed to assess glycemic control off liraglutide. The glimepiride-metformin combination carries hypoglycemia risk, particularly with glimepiride (7.5-27.4% incidence when combined with metformin) 3.

If urinary retention is confirmed, consider that poorly controlled diabetes may contribute to autonomic neuropathy affecting bladder function 7.

Follow-Up Parameters

  • Repeat PVR measurement after 2-4 weeks of treatment
  • If symptoms persist despite negative cultures, refer to urology for cystoscopy and urodynamic evaluation 7
  • Monitor for recurrent UTI (>2 in 6 months or >3 in 1 year would indicate recurrent UTI requiring prevention strategies) 9

The abdominal distention rated 8/10 with constant pressure is concerning—if this persists after addressing urinary retention, consider imaging (CT abdomen/pelvis) to rule out other intra-abdominal pathology unrelated to the bladder.

References

6
Research

Underactive urinary bladder - Masquerading as abdominal ascites.

Journal of family medicine and primary care, 2022

Related Questions

What is the appropriate evaluation and urgent management for a patient presenting with absent bladder sensation and urinary leakage?
What is the workup for incomplete bladder emptying?
What is the appropriate work‑up and management for a 60‑year‑old diabetic patient on glimepiride 4 mg who presents with a one‑week history of cough, fever, throat congestion, reduced breath sounds in the right upper lung zone, and an old healed foot ulcer?
How should the diabetes treatment be adjusted for a patient with an A1c of 9.9% who is currently taking insulin glargine (Lantus) 54 units daily, metformin 1000 mg twice daily, and glipizide 7.5 mg twice daily?
What evaluations and management should be recommended for a 38‑year‑old woman with a five‑year history of urinary frequency, intermittent shakiness and weakness, dry eyes, cold extremities, coarse chin hair, leukocytosis, hypoglycemia, vitamin D deficiency, borderline thyroid antibodies, elevated DHEA and mild hyperandrogenism?
What is the maximum dose of doxazosin for hypertension?
What is the recommended topical treatment regimen for a patient with mild-to-moderate plaque psoriasis?
What is the recommended intravenous (IV) bolus dose of labetalol for an adult with acute severe hypertension or hypertensive emergency, and how should the dose be adjusted for pediatric patients?
Which statement is NOT true regarding a 20‑year‑old patient with familial Mediterranean fever?
What are the discharge guidelines and plan for a patient with a possible scaphoid fracture?
What is the recommended treatment for influenza in the United States?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.